Modified clostridial toxins with enhanced translocation capability and enhanced targeting activity

Details for Australian Patent Application No. 2007347781 (hide)

Owner Allergan, Inc.

Inventors Fernandez-Salas, Ester; Steward, Lance E.; Francis, Joseph; Aoki, Kei Roger; Li, Shengwen; Gilmore, Marcella A.

Agent Davies Collison Cave

Pub. Number AU-A-2007347781

PCT Pub. Number WO2008/105901

Priority 60/807,063 11.07.06 US

Filing date 10 July 2007

Wipo publication date 4 September 2008

International Classifications

C07K 14/19 (2006.01) Peptides having more than 20 amino acids

Event Publications

5 February 2009 PCT application entered the National Phase

  PCT publication WO2008/105901 Priority application(s): WO2008/105901

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2007347785-Methods and compositions for improved enzyme activity in transgenic plants

2007347778-Reconfigurable data processing system